Keio University, abbreviated as Keio or Keidai, is a private research university located in Minato, Tokyo, Japan. It is the oldest institute of western higher education in Japan. Its founder, Fukuzawa Yukichi, originally established it as a school for Western studies in 1858 in Edo.

During the past decade, Keio University conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Keio University" #1 sponsor was "Haruhiko Fukuda" with 6 trials, followed by "National Cancer Institute (NCI)" with 4 trials sponsored, "Gynecologic Oncology Group" with 2 trials sponsored, "Chiba University" with 1 trials sponsored and "Children's Oncology Group" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Keio University" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 7 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator and "Saitama Medical University" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Keio University" are "Fallopian Tube Clear Cell Adenocarcinoma" (2 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (2 trials), "Fallopian Tube Mucinous Adenocarcinoma" (2 trials), "Fallopian Tube Serous Adenocarcinoma" (2 trials) and "Fallopian Tube Transitional Cell Carcinoma" (2 trials). Many other conditions were trialed in "Keio University" in a lesser frequency.

Most popular intervention types in "Keio University" are "Drug" (12 trials), "Other" (8 trials), "Procedure" (6 trials), "Biological" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (5 trials), "Laboratory Biomarker Analysis" (5 trials), "Paclitaxel" (5 trials), "Quality-of-Life Assessment" (4 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Keio University" are 10 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Keio University". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Keio University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Keio University, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".